isoleucyl-lysyl-valyl-alanyl-valine has been researched along with Cicatrix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, H; Jiang, T; Li, S; Liu, K; Qiu, T; Xu, B | 1 |
| Birch, D; Czeisler, C; Fehlings, MG; Kessler, JA; Niece, KL; Sahni, V; Stupp, SI; Tysseling-Mattiace, VM | 1 |
2 other study(ies) available for isoleucyl-lysyl-valyl-alanyl-valine and Cicatrix
| Article | Year |
|---|---|
IKVAV peptide-containing hydrogel decreases fibrous scar after spinal cord injury by inhibiting fibroblast migration and activation.
Topics: Animals; Cicatrix; Humans; Hydrogels; Mice; Peptides; Rats; Spinal Cord; Spinal Cord Injuries; Transforming Growth Factor beta1 | 2023 |
Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury.
Topics: Analysis of Variance; Animals; Apoptosis; Axons; Caspase 3; Cicatrix; Diagnostic Imaging; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Gliosis; Laminin; Mice; Motor Neurons; Nerve Regeneration; Neuroglia; Peptide Fragments; Recovery of Function; Spinal Cord Injuries; Time Factors | 2008 |